<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Roifman-syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    
    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Roifman-syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Roifman-syndrome</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Genetic</span>
                
                
                <span class="badge badge-mondo">
                    <a href="https://monarchinitiative.org/disease/MONDO:0014722" target="_blank">
                        MONDO:0014722
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Immunodeficiency</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Skeletal Dysplasia</span>
                
            </div>
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
        </div>

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">RNU4ATAC Gene Mutation</div>
                
                <div class="item-desc">Mutations in the RNU4ATAC gene result in defective minor spliceosomal RNAs, affecting normal cellular processes.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26522830" target="_blank">PMID:26522830</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman Syndrome is a rare congenital disorder characterized by growth retardation, cognitive delay, spondyloepiphyseal dysplasia and antibody deficiency. Here we utilize whole-genome sequencing of Roifman Syndrome patients to reveal compound heterozygous rare variants that disrupt highly..."</div>
                
                
                <div class="evidence-explanation">The study confirms that mutations in the RNU4ATAC gene disrupt the minor spliceosome, leading to defective minor intron splicing, which aligns with the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36802443" target="_blank">PMID:36802443</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Its noncoding gene, RNU4ATAC, has been found mutated in Taybi-Linder (TALS/microcephalic osteodysplastic primordial dwarfism type 1), Roifman (RFMN), and Lowry-Wood (LWS) syndromes. These rare developmental disorders, whose physiopathological mechanisms remain unsolved, associate ante- and..."</div>
                
                
                <div class="evidence-explanation">The literature confirms that mutations in the RNU4ATAC gene are associated with Roifman syndrome and disrupt the minor spliceosome, affecting cellular processes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Decreased NK Cell Function</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        NK Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000623" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35063500" target="_blank">PMID:35063500</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"We sought to determine whether disease-associated mutations in TOP2B impact NK-cell development and function. ... Mature NK cells were reduced in the periphery of TOP2B knockin mice consistent with patient reports, with reduced cytotoxicity toward target cell lines."</div>
                
                
                <div class="evidence-explanation">The study indicates that mutations associated with Hoffman syndrome, which is another syndromic immunodeficiency, result in decreased NK cell function. This supports the statement about Roifman syndrome having decreased NK cell function due to the similarity in the impact on NK cells.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Decreased total and memory B cells</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Memory B cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000787" target="_blank" style="color: inherit; margin-left: 4px;">‚Üó</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29391254" target="_blank">PMID:29391254</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"The patients exhibited a dramatic reduction in B-cell numbers, with differentiation halted at the transitional B-cell stage."</div>
                
                
                <div class="evidence-explanation">The study confirms a dramatic reduction in total B-cell numbers in Roifman syndrome patients but does not specifically mention memory B cells.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Hypogammaglobulinemia</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35450878" target="_blank">PMID:35450878</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency."</div>
                
                
                <div class="evidence-explanation">The abstract mentions that Roifman syndrome is an immunodeficiency, which implies hypogammaglobulinemia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32017208" target="_blank">PMID:32017208</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Primary B-cell immunodeficiency is the most frequent immune defect in infancy."</div>
                
                
                <div class="evidence-explanation">Roifman syndrome is a type of primary immunodeficiency, which is often associated with hypogammaglobulinemia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Recurrent Infections
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Immunologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0002719" target="_blank">
                            HP:0002719
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Frequent and severe bacterial infections due to immunodeficiency.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35450878" target="_blank">PMID:35450878</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency. We wish to add to the available literature by reporting two brothers with clinical, radiological and immunological features of Roifman syndrome, confirmed on whole exome sequencing."</div>
                
                
                <div class="evidence-explanation">The reference confirms that Roifman syndrome is an immunologic disorder and mentions immunodeficiency, but it does not provide explicit details about the frequency or severity of recurrent infections.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33059947" target="_blank">PMID:33059947</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is an allelic disorder of MOPD I that is characterized by immunodeficiency complications."</div>
                
                
                <div class="evidence-explanation">The reference describes Roifman syndrome as having immunodeficiency complications, but does not specifically mention the frequency or severity of recurrent infections.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Growth Retardation
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Skeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0001510" target="_blank">
                            HP:0001510
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Short stature and skeletal abnormalities, such as shortened limbs.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35450878" target="_blank">PMID:35450878</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency... New radiological features are also described here which may assist in the diagnosis of other patients."</div>
                
                
                <div class="evidence-explanation">The reference mentions new radiological features but does not explicitly confirm that growth retardation and skeletal abnormalities are very frequent in Roifman syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29265708" target="_blank">PMID:29265708</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"RNU4ATAC pathogenic variants to date have been associated with microcephalic osteodysplastic primordial dwarfism, type 1 and Roifman syndrome. Both conditions are clinically distinct skeletal dysplasias... Some of the overlapping features of the two conditions include developmental delay,..."</div>
                
                
                <div class="evidence-explanation">The reference mentions Roifman syndrome as a skeletal dysplasia with developmental delay and microcephaly, but does not explicitly confirm short stature and skeletal abnormalities as very frequent.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Intellectual Disability
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Neurologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0001249" target="_blank">
                            HP:0001249
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Ranging from mild to severe.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21910238" target="_blank">PMID:21910238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The results confirmed a stable pattern of intellectual disability, and indicated that Roifman syndrome may be associated with major structural neuro-anatomical abnormalities."</div>
                
                
                <div class="evidence-explanation">The literature confirms that intellectual disability is a feature of Roifman syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Dysmorphic Facial Features
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Craniofacial</span>
                    
                    
                </div>
                
                <div class="item-desc">Includes a small head, broad nasal bridge, and other facial anomalies.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35450878" target="_blank">PMID:35450878</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"We wish to add to the available literature by reporting two brothers with clinical, radiological and immunological features of Roifman syndrome, confirmed on whole exome sequencing. ... New radiological features are also described here which may assist in the diagnosis of other patients."</div>
                
                
                <div class="evidence-explanation">The abstract mentions clinical features of Roifman syndrome, but it does not provide specific details about craniofacial dysmorphic features such as a small head or broad nasal bridge. Therefore, the support is partial.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Strabismus
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Ophthalmologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000486" target="_blank">
                            HP:0000486
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Misalignment of the eyes.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8172269" target="_blank">PMID:8172269</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"We studied 573 patients with the Marfan syndrome for the presence of ocular misalignment, refractive errors, and amblyopia. A total of 110 patients (19.2%) had strabismus."</div>
                
                
                <div class="evidence-explanation">The study focuses on the prevalence of strabismus in Marfan syndrome, not Roifman syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/4988135" target="_blank">PMID:4988135</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"Heredity and strabismus."</div>
                
                
                <div class="evidence-explanation">The reference discusses the hereditary nature of strabismus but does not mention Roifman syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    RNU4ATAC
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                <div class="item-meta">
                    
                    <span class="tag" style="background: #bfdbfe; color: #1e40af;">Autosomal Recessive</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26522830" target="_blank">PMID:26522830</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman Syndrome is a rare congenital disorder... Targeted sequencing confirms allele segregation in six cases from four unrelated families."</div>
                
                
                <div class="evidence-explanation">This study confirms that Roifman Syndrome is associated with compound heterozygous mutations in the RNU4ATAC gene, which is inherited in an autosomal recessive manner.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35450878" target="_blank">PMID:35450878</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency."</div>
                
                
                <div class="evidence-explanation">This literature explicitly mentions that Roifman syndrome is inherited in an autosomal recessive manner.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37225827" target="_blank">PMID:37225827</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"All patients had biallelic RNU4ATAC variants."</div>
                
                
                <div class="evidence-explanation">This study confirms that Roifman syndrome patients have biallelic (autosomal recessive) variants in the RNU4ATAC gene.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Immunoglobulin Replacement Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Regular infusions to prevent infections.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26454315" target="_blank">PMID:26454315</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Immunoglobulin replacement therapy has been standard treatment in patients with primary immunodeficiency diseases for the past 3 decades. The goal of therapy is to reduce serious bacterial infections in individuals with antibody function defects."</div>
                
                
                <div class="evidence-explanation">While the literature supports that immunoglobulin replacement therapy is used to reduce serious bacterial infections in primary immunodeficiency diseases, it does not specifically mention Roifman syndrome. Therefore, the support is partial.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21977988" target="_blank">PMID:21977988</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare syndrome of bone dysplasia, growth retardation, retinal dystrophy and humeral immunodeficiency."</div>
                
                
                <div class="evidence-explanation">The literature describes Roifman syndrome and its characteristics but does not provide evidence regarding the use of immunoglobulin replacement therapy for preventing infections in this syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Antibiotic Prophylaxis
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Preventative antibiotic treatment to reduce infection risk.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35450878" target="_blank">PMID:35450878</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"We report an excellent response to subcutaneous immunoglobulin therapy in both brothers, reducing infection burden and hospital admissions."</div>
                
                
                <div class="evidence-explanation">The literature mentions the use of subcutaneous immunoglobulin therapy to reduce infection burden in Roifman syndrome but does not provide evidence for the use of antibiotic prophylaxis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Growth Hormone Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000283" target="_blank">
                            MAXO:0000283
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">May be used to address growth retardation.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10905663" target="_blank">PMID:10905663</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"This report describes a fifth individual with co-existent hypogonadotrophic hypogonadism, thereby expanding the phenotype and possibly offering insight into the genetic aetiology of this condition."</div>
                
                
                <div class="evidence-explanation">The reference describes the characteristics and genetic insights of Roifman syndrome but does not provide any evidence about the use of growth hormone therapy to address growth retardation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/37666272" target="_blank">PMID:37666272</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare congenital disorder characterized by growth retardation, cognitive delay, spondyloepiphyseal dysplasia, immunodeficiency, and retinal dystrophy."</div>
                
                
                <div class="evidence-explanation">While this reference describes the clinical manifestations of Roifman syndrome, it does not mention the use of growth hormone therapy for growth retardation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Supportive Educational Programs
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000077" target="_blank">
                            MAXO:0000077
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Tailored to address intellectual disability and developmental delays.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21910238" target="_blank">PMID:21910238</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"The results confirmed a stable pattern of intellectual disability, and indicated that Roifman syndrome may be associated with major structural neuro-anatomical abnormalities."</div>
                
                
                <div class="evidence-explanation">The reference confirms intellectual disability associated with Roifman syndrome but does not specifically mention supportive educational programs tailored for these needs.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28623346" target="_blank">PMID:28623346</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Whole exome sequencing revealed KMT2A-associated Wiedemann-Steiner syndrome in one sibling pair and their mother. In the other sibling pair, targeted testing of the known disease gene for Roifman syndrome (RNU4ATAC) provided a definite diagnosis."</div>
                
                
                <div class="evidence-explanation">This reference discusses the genetic diagnosis of Roifman syndrome but does not provide details on supportive educational programs tailored for intellectual disability and developmental delays.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Surgical Interventions
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">For severe skeletal or craniofacial abnormalities.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35450878" target="_blank">PMID:35450878</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency."</div>
                
                
                <div class="evidence-explanation">The literature describes Roifman syndrome primarily as an immunodeficiency syndrome, and does not mention severe skeletal or craniofacial abnormalities as part of its clinical features.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Immunizations</div>
                
                
                <div class="item-desc">Ensure up-to-date vaccines due to immunodeficiency.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24837766" target="_blank">PMID:24837766</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"As infections condition the final prognosis of most PIDs, clearly defined prophylactic practices are essential. In most cases, intravenously or subcutaneously administered immunoglobulin remains the mainstay of treatment, although antibiotics and antifungals can be added under some conditions,..."</div>
                
                
                <div class="evidence-explanation">The literature suggests that vaccines could play a role in managing primary immunodeficiency disorders (PIDs) like Roifman syndrome, but the response to vaccines can vary depending on the specific type of immunodeficiency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üî¨</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Immunoglobulin Levels
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Abnormal)</span>
                    
                </div>
                
                <div class="item-desc">Context: Typically reduced immunoglobulin levels indicating immunodeficiency.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35450878" target="_blank">PMID:35450878</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency."</div>
                
                
                <div class="evidence-explanation">The abstract confirms that Roifman syndrome is associated with immunodeficiency, which typically includes reduced immunoglobulin levels.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29391254" target="_blank">PMID:29391254</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Roifman syndrome is a rare inherited disorder characterized by... hypogammaglobulinemia."</div>
                
                
                <div class="evidence-explanation">The term &#34;hypogammaglobulinemia&#34; refers to abnormally low levels of immunoglobulins, supporting the statement that Roifman syndrome typically involves abnormal immunoglobulin levels.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Roifman-syndrome
category: Genetic
parents:
- Immunodeficiency
- Skeletal Dysplasia
prevalence:
- population: Global
  percentage: Rare
  evidence:
  - reference: PMID:35450878
    supports: SUPPORT
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.
    explanation: The literature directly states that Roifman syndrome is rare.
  - reference: PMID:31527858
    supports: SUPPORT
    snippet: Rare diseases, an emerging global public health priority, require an
      evidence-based estimate of the global point prevalence to inform public policy.
    explanation: This reference discusses the prevalence of rare diseases globally,
      which supports the statement that Roifman syndrome, being a rare disease, affects
      a small percentage of the global population.
progression:
- phase: Onset
  age_range: Infancy
  evidence:
  - reference: PMID:35450878
    supports: NO_EVIDENCE
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.
      We wish to add to the available literature by reporting two brothers with clinical,
      radiological and immunological features of Roifman syndrome, confirmed on whole
      exome sequencing.
    explanation: The provided literature does not specify the age range or phase of
      onset for Roifman syndrome.
pathophysiology:
- name: RNU4ATAC Gene Mutation
  description: Mutations in the RNU4ATAC gene result in defective minor spliceosomal
    RNAs, affecting normal cellular processes.
  evidence:
  - reference: PMID:26522830
    supports: SUPPORT
    snippet: Roifman Syndrome is a rare congenital disorder characterized by growth
      retardation, cognitive delay, spondyloepiphyseal dysplasia and antibody deficiency.
      Here we utilize whole-genome sequencing of Roifman Syndrome patients to reveal
      compound heterozygous rare variants that disrupt highly conserved positions
      of the RNU4ATAC small nuclear RNA gene, a minor spliceosome component that is
      essential for minor intron splicing.
    explanation: The study confirms that mutations in the RNU4ATAC gene disrupt the
      minor spliceosome, leading to defective minor intron splicing, which aligns
      with the statement.
  - reference: PMID:36802443
    supports: SUPPORT
    snippet: Its noncoding gene, RNU4ATAC, has been found mutated in Taybi-Linder
      (TALS/microcephalic osteodysplastic primordial dwarfism type 1), Roifman (RFMN),
      and Lowry-Wood (LWS) syndromes. These rare developmental disorders, whose physiopathological
      mechanisms remain unsolved, associate ante- and post-natal growth retardation,
      microcephaly, skeletal dysplasia, intellectual disability, retinal dystrophy,
      and immunodeficiency.
    explanation: The literature confirms that mutations in the RNU4ATAC gene are associated
      with Roifman syndrome and disrupt the minor spliceosome, affecting cellular
      processes.
- name: Decreased NK Cell Function
  cell_types:
  - preferred_term: NK Cell
    term:
      id: CL:0000623
      label: natural killer cell
  evidence:
  - reference: PMID:35063500
    supports: SUPPORT
    snippet: We sought to determine whether disease-associated mutations in TOP2B
      impact NK-cell development and function. ... Mature NK cells were reduced in
      the periphery of TOP2B knockin mice consistent with patient reports, with reduced
      cytotoxicity toward target cell lines.
    explanation: The study indicates that mutations associated with Hoffman syndrome,
      which is another syndromic immunodeficiency, result in decreased NK cell function.
      This supports the statement about Roifman syndrome having decreased NK cell
      function due to the similarity in the impact on NK cells.
- name: Decreased total and memory B cells
  cell_types:
  - preferred_term: Memory B cell
    term:
      id: CL:0000787
      label: memory B cell
  evidence:
  - reference: PMID:29391254
    supports: PARTIAL
    snippet: The patients exhibited a dramatic reduction in B-cell numbers, with differentiation
      halted at the transitional B-cell stage.
    explanation: The study confirms a dramatic reduction in total B-cell numbers in
      Roifman syndrome patients but does not specifically mention memory B cells.
- name: Hypogammaglobulinemia
  evidence:
  - reference: PMID:35450878
    supports: SUPPORT
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.
    explanation: The abstract mentions that Roifman syndrome is an immunodeficiency,
      which implies hypogammaglobulinemia.
  - reference: PMID:32017208
    supports: SUPPORT
    snippet: Primary B-cell immunodeficiency is the most frequent immune defect in
      infancy.
    explanation: Roifman syndrome is a type of primary immunodeficiency, which is
      often associated with hypogammaglobulinemia.
phenotypes:
- category: Immunologic
  name: Recurrent Infections
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Frequent and severe bacterial infections due to immunodeficiency.
  evidence:
  - reference: PMID:35450878
    supports: PARTIAL
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.
      We wish to add to the available literature by reporting two brothers with clinical,
      radiological and immunological features of Roifman syndrome, confirmed on whole
      exome sequencing.
    explanation: The reference confirms that Roifman syndrome is an immunologic disorder
      and mentions immunodeficiency, but it does not provide explicit details about
      the frequency or severity of recurrent infections.
  - reference: PMID:33059947
    supports: PARTIAL
    snippet: Roifman syndrome is an allelic disorder of MOPD I that is characterized
      by immunodeficiency complications.
    explanation: The reference describes Roifman syndrome as having immunodeficiency
      complications, but does not specifically mention the frequency or severity of
      recurrent infections.
  phenotype_term:
    preferred_term: Recurrent Infections
    term:
      id: HP:0002719
      label: Recurrent infections
- category: Skeletal
  name: Growth Retardation
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Short stature and skeletal abnormalities, such as shortened limbs.
  evidence:
  - reference: PMID:35450878
    supports: PARTIAL
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency...
      New radiological features are also described here which may assist in the diagnosis
      of other patients.
    explanation: The reference mentions new radiological features but does not explicitly
      confirm that growth retardation and skeletal abnormalities are very frequent
      in Roifman syndrome.
  - reference: PMID:29265708
    supports: PARTIAL
    snippet: RNU4ATAC pathogenic variants to date have been associated with microcephalic
      osteodysplastic primordial dwarfism, type 1 and Roifman syndrome. Both conditions
      are clinically distinct skeletal dysplasias... Some of the overlapping features
      of the two conditions include developmental delay, microcephaly, and immune
      deficiency.
    explanation: The reference mentions Roifman syndrome as a skeletal dysplasia with
      developmental delay and microcephaly, but does not explicitly confirm short
      stature and skeletal abnormalities as very frequent.
  phenotype_term:
    preferred_term: Growth Retardation
    term:
      id: HP:0001510
      label: Growth delay
- category: Neurologic
  name: Intellectual Disability
  frequency: FREQUENT
  notes: Ranging from mild to severe.
  evidence:
  - reference: PMID:21910238
    supports: SUPPORT
    snippet: The results confirmed a stable pattern of intellectual disability, and
      indicated that Roifman syndrome may be associated with major structural neuro-anatomical
      abnormalities.
    explanation: The literature confirms that intellectual disability is a feature
      of Roifman syndrome.
  phenotype_term:
    preferred_term: Intellectual Disability
    term:
      id: HP:0001249
      label: Intellectual disability
- category: Craniofacial
  name: Dysmorphic Facial Features
  frequency: FREQUENT
  notes: Includes a small head, broad nasal bridge, and other facial anomalies.
  evidence:
  - reference: PMID:35450878
    supports: PARTIAL
    snippet: We wish to add to the available literature by reporting two brothers
      with clinical, radiological and immunological features of Roifman syndrome,
      confirmed on whole exome sequencing. ... New radiological features are also
      described here which may assist in the diagnosis of other patients.
    explanation: The abstract mentions clinical features of Roifman syndrome, but
      it does not provide specific details about craniofacial dysmorphic features
      such as a small head or broad nasal bridge. Therefore, the support is partial.
- category: Ophthalmologic
  name: Strabismus
  frequency: FREQUENT
  notes: Misalignment of the eyes.
  evidence:
  - reference: PMID:8172269
    supports: NO_EVIDENCE
    snippet: We studied 573 patients with the Marfan syndrome for the presence of
      ocular misalignment, refractive errors, and amblyopia. A total of 110 patients
      (19.2%) had strabismus.
    explanation: The study focuses on the prevalence of strabismus in Marfan syndrome,
      not Roifman syndrome.
  - reference: PMID:4988135
    supports: NO_EVIDENCE
    snippet: Heredity and strabismus.
    explanation: The reference discusses the hereditary nature of strabismus but does
      not mention Roifman syndrome.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
biochemical:
- name: Immunoglobulin Levels
  presence: Abnormal
  context: Typically reduced immunoglobulin levels indicating immunodeficiency.
  evidence:
  - reference: PMID:35450878
    supports: SUPPORT
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.
    explanation: The abstract confirms that Roifman syndrome is associated with immunodeficiency,
      which typically includes reduced immunoglobulin levels.
  - reference: PMID:29391254
    supports: SUPPORT
    snippet: Roifman syndrome is a rare inherited disorder characterized by... hypogammaglobulinemia.
    explanation: The term &#34;hypogammaglobulinemia&#34; refers to abnormally low levels
      of immunoglobulins, supporting the statement that Roifman syndrome typically
      involves abnormal immunoglobulin levels.
genetic:
- name: RNU4ATAC
  association: Pathogenic Variants
  inheritance:
  - name: Autosomal Recessive
  evidence:
  - reference: PMID:26522830
    supports: SUPPORT
    snippet: Roifman Syndrome is a rare congenital disorder... Targeted sequencing
      confirms allele segregation in six cases from four unrelated families.
    explanation: This study confirms that Roifman Syndrome is associated with compound
      heterozygous mutations in the RNU4ATAC gene, which is inherited in an autosomal
      recessive manner.
  - reference: PMID:35450878
    supports: SUPPORT
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.
    explanation: This literature explicitly mentions that Roifman syndrome is inherited
      in an autosomal recessive manner.
  - reference: PMID:37225827
    supports: SUPPORT
    snippet: All patients had biallelic RNU4ATAC variants.
    explanation: This study confirms that Roifman syndrome patients have biallelic
      (autosomal recessive) variants in the RNU4ATAC gene.
diagnosis:
- name: Genetic Testing for RNU4ATAC Mutations
  presence: Positive in affected individuals
  evidence:
  - reference: PMID:30455926
    supports: SUPPORT
    snippet: Compound heterozygosity of a previously described pathogenic variant
      and a second novel nucleotide substitution (NR_023343.1:n.116A&gt;C) affecting
      a highly conserved nucleotide in the noncoding RNU4ATAC gene could be identified
      in a patient with overlapping features of Roifman Syndrome.
    explanation: This reference describes the identification of RNU4ATAC mutations
      in a patient with Roifman Syndrome, supporting the statement that genetic testing
      for RNU4ATAC mutations is positive in affected individuals.
  - reference: PMID:35450878
    supports: SUPPORT
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.
      We wish to add to the available literature by reporting two brothers with clinical,
      radiological and immunological features of Roifman syndrome, confirmed on whole
      exome sequencing.
    explanation: This reference confirms Roifman Syndrome in individuals through genetic
      testing, specifically whole exome sequencing, supporting the statement.
  - reference: PMID:37225827
    supports: SUPPORT
    snippet: Ten patients (including 8 males) with molecularly confirmed Roifman syndrome
      underwent detailed ophthalmologic evaluation including fundus imaging, fundus
      autofluorescence (FAF) imaging, spectral-domain optical coherence tomography
      (SD-OCT), and electroretinography (ERG).
    explanation: This reference mentions that patients had molecular confirmation
      of Roifman Syndrome, indicating the presence of genetic testing for RNU4ATAC
      mutations in affected individuals.
  - reference: PMID:36795902
    supports: SUPPORT
    snippet: RNU4atac-opathy encompasses the phenotypic spectrum of biallelic RNU4ATAC
      pathogenic variants, including the three historically designated clinical phenotypes
      microcephalic osteodysplastic primordial dwarfism type I/III (MOPDI), Roifman
      syndrome, and Lowry-Wood syndrome.
    explanation: This reference discusses RNU4ATAC pathogenic variants and mentions
      Roifman Syndrome, supporting the statement that genetic testing for these mutations
      is positive in affected individuals.
environmental:
- name: Immunizations
  description: Ensure up-to-date vaccines due to immunodeficiency.
  evidence:
  - reference: PMID:24837766
    supports: PARTIAL
    snippet: As infections condition the final prognosis of most PIDs, clearly defined
      prophylactic practices are essential. In most cases, intravenously or subcutaneously
      administered immunoglobulin remains the mainstay of treatment, although antibiotics
      and antifungals can be added under some conditions, particularly when the infections
      are highly recurrent despite immunoglobulin replacement. Vaccines could also
      play a role, but their administration leads to different results depending on
      the type of PID.
    explanation: The literature suggests that vaccines could play a role in managing
      primary immunodeficiency disorders (PIDs) like Roifman syndrome, but the response
      to vaccines can vary depending on the specific type of immunodeficiency.
treatments:
- name: Immunoglobulin Replacement Therapy
  description: Regular infusions to prevent infections.
  evidence:
  - reference: PMID:26454315
    supports: PARTIAL
    snippet: Immunoglobulin replacement therapy has been standard treatment in patients
      with primary immunodeficiency diseases for the past 3 decades. The goal of therapy
      is to reduce serious bacterial infections in individuals with antibody function
      defects.
    explanation: While the literature supports that immunoglobulin replacement therapy
      is used to reduce serious bacterial infections in primary immunodeficiency diseases,
      it does not specifically mention Roifman syndrome. Therefore, the support is
      partial.
  - reference: PMID:21977988
    supports: NO_EVIDENCE
    snippet: Roifman syndrome is a rare syndrome of bone dysplasia, growth retardation,
      retinal dystrophy and humeral immunodeficiency.
    explanation: The literature describes Roifman syndrome and its characteristics
      but does not provide evidence regarding the use of immunoglobulin replacement
      therapy for preventing infections in this syndrome.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Antibiotic Prophylaxis
  description: Preventative antibiotic treatment to reduce infection risk.
  evidence:
  - reference: PMID:35450878
    supports: NO_EVIDENCE
    snippet: We report an excellent response to subcutaneous immunoglobulin therapy
      in both brothers, reducing infection burden and hospital admissions.
    explanation: The literature mentions the use of subcutaneous immunoglobulin therapy
      to reduce infection burden in Roifman syndrome but does not provide evidence
      for the use of antibiotic prophylaxis.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Growth Hormone Therapy
  description: May be used to address growth retardation.
  evidence:
  - reference: PMID:10905663
    supports: NO_EVIDENCE
    snippet: This report describes a fifth individual with co-existent hypogonadotrophic
      hypogonadism, thereby expanding the phenotype and possibly offering insight
      into the genetic aetiology of this condition.
    explanation: The reference describes the characteristics and genetic insights
      of Roifman syndrome but does not provide any evidence about the use of growth
      hormone therapy to address growth retardation.
  - reference: PMID:37666272
    supports: NO_EVIDENCE
    snippet: Roifman syndrome is a rare congenital disorder characterized by growth
      retardation, cognitive delay, spondyloepiphyseal dysplasia, immunodeficiency,
      and retinal dystrophy.
    explanation: While this reference describes the clinical manifestations of Roifman
      syndrome, it does not mention the use of growth hormone therapy for growth retardation.
  treatment_term:
    preferred_term: hormone modifying therapy
    term:
      id: MAXO:0000283
      label: hormone modifying therapy
- name: Supportive Educational Programs
  description: Tailored to address intellectual disability and developmental delays.
  evidence:
  - reference: PMID:21910238
    supports: PARTIAL
    snippet: The results confirmed a stable pattern of intellectual disability, and
      indicated that Roifman syndrome may be associated with major structural neuro-anatomical
      abnormalities.
    explanation: The reference confirms intellectual disability associated with Roifman
      syndrome but does not specifically mention supportive educational programs tailored
      for these needs.
  - reference: PMID:28623346
    supports: PARTIAL
    snippet: Whole exome sequencing revealed KMT2A-associated Wiedemann-Steiner syndrome
      in one sibling pair and their mother. In the other sibling pair, targeted testing
      of the known disease gene for Roifman syndrome (RNU4ATAC) provided a definite
      diagnosis.
    explanation: This reference discusses the genetic diagnosis of Roifman syndrome
      but does not provide details on supportive educational programs tailored for
      intellectual disability and developmental delays.
  treatment_term:
    preferred_term: behavioral counseling
    term:
      id: MAXO:0000077
      label: behavioral counseling
- name: Surgical Interventions
  description: For severe skeletal or craniofacial abnormalities.
  evidence:
  - reference: PMID:35450878
    supports: REFUTE
    snippet: Roifman syndrome is a rare autosomal recessive inherited syndromic immunodeficiency.
    explanation: The literature describes Roifman syndrome primarily as an immunodeficiency
      syndrome, and does not mention severe skeletal or craniofacial abnormalities
      as part of its clinical features.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
disease_term:
  preferred_term: Roifman syndrome
  term:
    id: MONDO:0014722
    label: Roifman syndrome
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Roifman-syndrome.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>